Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of tobramycin inhalation powder (TIP) over 6 treatment cycles in cystic fibrosis patients with Pseudomonas aeruginosa
2011-002000-32Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tobramycin in cystic fibrosis (CF), Pseudomonal infection, sponsored by Novartis. Started Sep 2011; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2011-002000-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002000-32.